SENS Foundation was founded to develop, promote and ensure widespread access to regenerative medicine solutions to the disabilities and diseases of aging. We shall be focusing on the Strategies for Engineered Negligible Senescence (SENS) identified by our Chief Science Officer, Dr Aubrey de Grey, and combining direct research efforts with education, affiliation and outreach programs. You can find more about us, our mission and our history by following the links in the menu above.
SENS Foundation would like to draw your attention to an exciting initiative organised by a group of our supporters. The 10,000 people, $1 million to defeat aging Cause on Facebook asks each member to pledge just $100, which becomes payable once a total of 10,000 individuals have made the same pledge.
Those 10,000 donations will provide SENS Foundation with $1 million of additional funding, which will support our critical research into defeating the diseases and disabilities of aging. Over the course of 2010 we intend to increase funding to our LysoSENS program and ramp up work on MitoSENS, as well as continuing to pursue our work on atherosclerosis, immunosenescence, and macular degeneration.
The Cause has already assembled over 1,600 of the members required, and hopes to reach the 10,000-member target early this year. Please consider joining them.
Two of our founders, Chief Executive Officer Mike Kope and Dr de Grey, have written open letters to introduce you to our organization and its work. We hope that you will share the enthusiasm and confidence which they express, and support us as we deliver real progress in the engineering of comprehensive regenerative therapies.
